TBPH
Theravance Biopharma, Inc.
NASDAQ · Healthcare · Biotechnology · KY
$17.08
+0.00%Leverage
- Debt / equity
- 0.13x
- Net debt / equity
- -0.63x
- Debt / assets
- 0.08x
- Debt / EBITDA
- 0.56x
- Net debt / EBITDA
- -2.65x
Liquidity & coverage
- Current ratio
- 13.54x
- Quick ratio
- 13.54x
- Cash ratio
- 12.60x
- Interest coverage
- 4.03x
- EBITDA / interest
- 59.22x
- Working capital
- $385.9M
Cash & dividend
- FCF / debt
- 1.34x
- Cash flow / debt
- 1.34x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026